Thomas Wiesner

9.6k total citations · 2 hit papers
54 papers, 4.0k citations indexed

About

Thomas Wiesner is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, Thomas Wiesner has authored 54 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Molecular Biology and 11 papers in Dermatology. Recurrent topics in Thomas Wiesner's work include Cutaneous Melanoma Detection and Management (19 papers), Melanoma and MAPK Pathways (11 papers) and Cancer Genomics and Diagnostics (9 papers). Thomas Wiesner is often cited by papers focused on Cutaneous Melanoma Detection and Management (19 papers), Melanoma and MAPK Pathways (11 papers) and Cancer Genomics and Diagnostics (9 papers). Thomas Wiesner collaborates with scholars based in Austria, Germany and United States. Thomas Wiesner's co-authors include Klaus J. Busam, Rajmohan Murali, Heinz Kutzner, Lorenzo Cerroni, Anna C. Obenauf, Boris C. Bastian, Michael R. Speicher, Klaus Griewank, Richard A. Scolyer and Swapna S. Vemula and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Thomas Wiesner

52 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in GNA11 in Uveal Melanoma

2010 1.1k citations Klaus Griewank, Swapna S. Vemula et al. profile →
Therapy-induced tumour secretomes promote resistance and tumour progression

2015 364 citations Anna C. Obenauf, Yilong Zou et al. Nature profile →

Peers

Countries citing papers authored by Thomas Wiesner

Since Specialization

Citations

This map shows the geographic impact of Thomas Wiesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wiesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wiesner more than expected).

Fields of papers citing papers by Thomas Wiesner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wiesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wiesner. The network helps show where Thomas Wiesner may publish in the future.

Co-authorship network of co-authors of Thomas Wiesner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wiesner. A scholar is included among the top collaborators of Thomas Wiesner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wiesner. Thomas Wiesner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	LSD 1 inhibition induces differentiation and cell death in Merkel cell carcinoma 2020 ·EMBO Molecular Medicine ·(unknown), (unknown), (unknown), Tobias Neumann, Alexander Schleiffer, Karl Mechtler, Thomas Wiesner, Anna C. Obenauf	42
2	SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases 2020 ·British Journal of Dermatology ·Isabel Colmenero, Carlos Santonja, Marina Alonso, Lucero Noguera‐Morel, Á. Hernández‐Martín, David Andina Martínez, Thomas Wiesner, (unknown), Luis Requena, Antonio Torrelo	283
3	Leitlinie „Auditive Verarbeitungs- und Wahrnehmungsstörungen“: Differenzialdiagnose 2019 ·HNO ·A. Nickisch, Christiane Kiese-Himmel, Thomas Wiesner, R. Schönweiler	7
4	Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles 2017 ·Modern Pathology ·Klaus Griewank, Thomas Wiesner, Rajmohan Murali, (unknown), Hansgeorg Müller, Christian Koelsche, Inga Möller, Cindy Franklin, Ioana Cosgarea, Antje Sucker, Dirk Schadendorf, Jörg Schaller, Susanne Horn, Thomas Brenn, Thomas Mentzel	61
5	Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy 2016 ·Pathology ·Thomas Wiesner, Heinz Kutzner, Lorenzo Cerroni, Martín C. Mihm, Klaus J. Busam, Rajmohan Murali	123
6	Investigation of Somatic <b><i>GNAQ, GNA11, BAP1</i></b> and <b><i>SF3B1</i></b> Mutations in Ophthalmic Melanocytomas 2016 ·Ocular Oncology and Pathology ·Jasmine H. Francis, Thomas Wiesner, Tatyana Milman, Helen Won, Amy Lin, Vivian Lee, Daniel M. Albert, Robert Folberg, Michael F. Berger, Devron H. Char, Brian P. Marr, David H. Abramson	9
7	NF1 Mutations Are Common in Desmoplastic Melanoma 2015 ·The American Journal of Surgical Pathology ·Thomas Wiesner, Maija Kiuru, Sasinya N. Scott, Maria E. Arcila, Allan C. Halpern, Travis J. Hollmann, Michael F. Berger, Klaus J. Busam	79
8	Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST 2015 ·The American Journal of Surgical Pathology ·Carlos Prieto‐Granada, Thomas Wiesner, Jane L. Messina, Achim A. Jungbluth, Ping Chi, Cristina R. Antonescu	189
9	Therapy-induced tumour secretomes promote resistance and tumour progression breakdown → 2015 ·Nature ·Anna C. Obenauf, Yilong Zou, Andrew L. Ji, Sakari Vanharanta, Weiping Shu, Hubing Shi, Xiangju Kong, Marcus Bosenberg, Thomas Wiesner, Neal Rosen, Roger S. Lo, Joan Massagué	364
10	Clinical and Pathologic Findings of Spitz Nevi and Atypical Spitz Tumors With ALK Fusions 2014 ·The American Journal of Surgical Pathology ·Klaus J. Busam, Heinz Kutzner, Lorenzo Cerroni, Thomas Wiesner	118
11	Ambiguous Melanocytic Tumors With Loss of 3p21 2014 ·The American Journal of Surgical Pathology ·Iwei Yeh, Thaddeus W. Mully, Thomas Wiesner, Swapna S. Vemula, (unknown), (unknown), Timothy H. McCalmont, Boris C. Bastian, Philip E. LeBoit	56
12	Clinicopathologic and molecular features in cutaneous extranodal natural killer–/T-cell lymphoma, nasal type, with aggressive and indolent course 2014 ·Journal of the American Academy of Dermatology ·Isabella Fried, (unknown), Carlo Cota, Hansgeorg Müller, (unknown), Sebastiana Boi, Concetta Chiarelli, Esmeralda Vale, Matthias Schmuth, Thomas Wiesner, Michael R. Speicher, Lorenzo Cerroni	10
13	Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas 2013 ·Clinical Cancer Research ·Klaus Griewank, Henrike Westekemper, Rajmohan Murali, (unknown), Bastian Schilling, Thomas Wiesner, Tobias Schimming, Elisabeth Livingstone, Antje Sucker, Florian Grabellus, Claudia H.D. Metz, Daniela Süßkind, Uwe Hillen, Michael R. Speicher, Scott E. Woodman, (unknown), Dirk Schadendorf	159
14	Multiple Epithelioid Spitz Nevi or Tumors With Loss of BAP1 Expression 2013 ·JAMA Dermatology ·Klaus J. Busam, (unknown), Thomas Wiesner	30
15	A Distinct Subset of Atypical Spitz Tumors is Characterized by BRAF Mutation and Loss of BAP1 Expression 2012 ·The American Journal of Surgical Pathology ·Thomas Wiesner, Rajmohan Murali, Isabella Fried, Lorenzo Cerroni, Klaus J. Busam, Heinz Kutzner, Boris C. Bastian	180
16	A Proposal for Improving Multicolor FISH Sensitivity in the Diagnosis of Malignant Melanoma Using New Combined Criteria 2012 ·American Journal of Dermatopathology ·Katrin Kerl, Gabriele Palmedo, Thomas Wiesner, Thomas Mentzel, Arno Rütten, Leo Schärer, Bruno E. Paredes, Markus Hantschke, Heinz Kutzner	15
17	Cutaneous Lymphomas: from Morphology to Chip Technology 2009 ·Actas Dermo-Sifiliográficas ·Lorenzo Cerroni, Thomas Wiesner	5
18	Alterations of the Cell-Cycle Inhibitors p27KIP1 and p16INK4a Are Frequent in Blastic Plasmacytoid Dendritic Cell Neoplasms 2009 ·Journal of Investigative Dermatology ·Thomas Wiesner, Anna C. Obenauf, Carlo Cota, Isabella Fried, Michael R. Speicher, Lorenzo Cerroni	48
19	Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm—Morphologic and Phenotypic Variability in a Series of 33 Patients 2009 ·The American Journal of Surgical Pathology ·Carlo Cota, Esmeralda Vale, Isabel Viana, Luis Requena, Gerardo Ferrara, Lucia Anemona, Dieter Metze, Regina Fink‐Puches, Thomas Wiesner, Lorenzo Cerroni	116
20	Itch, skin lesions—and a stiff neck 2007 ·The Lancet ·Thomas Wiesner, Bernd Leinweber, Stefan Quasthoff, (unknown), Peter Komericki, (unknown), Helmut Kerl	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact